CR20140189S - Vacunas y metodos para crear una vacuna para inducir la inmunidad a todos los serotipos del virus del dengue - Google Patents
Vacunas y metodos para crear una vacuna para inducir la inmunidad a todos los serotipos del virus del dengueInfo
- Publication number
- CR20140189S CR20140189S CR20140189F CR20140189F CR20140189S CR 20140189 S CR20140189 S CR 20140189S CR 20140189 F CR20140189 F CR 20140189F CR 20140189 F CR20140189 F CR 20140189F CR 20140189 S CR20140189 S CR 20140189S
- Authority
- CR
- Costa Rica
- Prior art keywords
- vaccine
- serotips
- vaccines
- create
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Método para producir una proteína quimérica que tenga las porciones del virus de la fiebre amarilla y el virus del dengue. Una pequeña porción de la proteína de envoltura de la variedad de la vacuna 17D del virus de la fiebre amarilla (u otros flavivirus relacionados) puede ser reemplazada por la porción correspondiente de la proteína de envoltura del virus del dengue.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161550982P | 2011-10-25 | 2011-10-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20140189S true CR20140189S (es) | 2014-09-24 |
Family
ID=48168485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20140189F CR20140189S (es) | 2011-10-25 | 2014-04-25 | Vacunas y metodos para crear una vacuna para inducir la inmunidad a todos los serotipos del virus del dengue |
Country Status (9)
Country | Link |
---|---|
US (2) | US20150265694A1 (es) |
EP (1) | EP2771366A4 (es) |
CN (1) | CN104736568A (es) |
BR (1) | BR112014009887A2 (es) |
CR (1) | CR20140189S (es) |
HK (2) | HK1198770A1 (es) |
IN (1) | IN2014CN03925A (es) |
SG (1) | SG11201401733VA (es) |
WO (1) | WO2013063248A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013122262A1 (en) | 2012-02-16 | 2013-08-22 | Vlp Therapeutics, Llc | Virus like particle composition |
US9637532B2 (en) | 2013-07-12 | 2017-05-02 | Vlp Therapeutics, Llc | Virus like particle comprising PD-1 antigen or PD-1 ligand antigen |
EP3177720B1 (en) | 2014-08-08 | 2021-09-22 | VLP Therapeutics, Inc. | Virus like particle comprising modified envelope protein e3 |
US10385101B2 (en) | 2014-08-08 | 2019-08-20 | Vlp Therapeutics, Llc | Virus like particle comprising modified envelope protein E3 |
CA2960102C (en) * | 2014-09-11 | 2023-10-24 | Vlp Therapeutics, Llc | Flavivirus virus like particle |
CN105732777B (zh) * | 2016-05-05 | 2019-06-04 | 中国人民解放军军事医学科学院微生物流行病研究所 | 黄热病毒特异性检测抗原及其应用 |
EP3621645A4 (en) * | 2017-05-10 | 2021-01-27 | University of Massachusetts | BIVALENT DENGUE / HEPATITIS B VACCINES |
CN113651885B (zh) * | 2018-04-04 | 2022-04-15 | 中国科学院微生物研究所 | 一种高灵敏度的黄热病毒人源单克隆抗体及其应用 |
CN109627294B (zh) * | 2018-12-29 | 2020-10-09 | 四川大学 | 一种正确折叠的重组狂犬病毒g蛋白胞外段及其潜在应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2372991B (en) * | 2001-03-09 | 2004-11-17 | Fiocruz Fundacao Oswaldo Cruz | Flavivirus expression vector |
CN1551782A (zh) * | 2001-06-01 | 2004-12-01 | ��������ķ������ | 嵌合黄病毒载体 |
CN101287490B (zh) * | 2005-08-10 | 2013-04-24 | 阿坎姆比斯公司 | 对抗登革热病毒感染的疫苗接种 |
-
2012
- 2012-10-25 US US13/660,653 patent/US20150265694A1/en not_active Abandoned
- 2012-10-25 WO PCT/US2012/061893 patent/WO2013063248A1/en active Application Filing
- 2012-10-25 IN IN3925CHN2014 patent/IN2014CN03925A/en unknown
- 2012-10-25 EP EP12842872.9A patent/EP2771366A4/en not_active Withdrawn
- 2012-10-25 SG SG11201401733VA patent/SG11201401733VA/en unknown
- 2012-10-25 BR BR112014009887A patent/BR112014009887A2/pt not_active IP Right Cessation
- 2012-10-25 CN CN201280052904.8A patent/CN104736568A/zh active Pending
-
2014
- 2014-04-25 CR CR20140189F patent/CR20140189S/es unknown
- 2014-12-05 HK HK14112282.6A patent/HK1198770A1/xx unknown
-
2015
- 2015-07-21 HK HK15106951.7A patent/HK1206366A1/xx unknown
-
2017
- 2017-01-23 US US15/413,347 patent/US10124053B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN104736568A (zh) | 2015-06-24 |
SG11201401733VA (en) | 2014-09-26 |
WO2013063248A1 (en) | 2013-05-02 |
US20170202945A1 (en) | 2017-07-20 |
EP2771366A1 (en) | 2014-09-03 |
HK1198770A1 (en) | 2015-07-31 |
US20150265694A1 (en) | 2015-09-24 |
US10124053B2 (en) | 2018-11-13 |
IN2014CN03925A (es) | 2015-07-03 |
EP2771366A4 (en) | 2015-06-03 |
BR112014009887A2 (pt) | 2017-04-25 |
HK1206366A1 (en) | 2016-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20140189S (es) | Vacunas y metodos para crear una vacuna para inducir la inmunidad a todos los serotipos del virus del dengue | |
CL2016001580A1 (es) | Uso de compuestos derivados de indol para tratar una infección por flavivirus; compuestos derivados de indol; composiciones farmacéuticas; y uso de una combinación. | |
CL2018000515A1 (es) | Virus de la enfermedad de newcastle y usos de los mismos (divisional sol. 2532-2015) | |
PE20151071A1 (es) | Derivados de 5-fluoro-n-(piridin-2-il)piridin-2-amina que contienen un grupo sulfoximina | |
CR20130620A (es) | 4-aril-n-fenil-1,3,5-triazin-2-aminas que contienen un grupo sulfoximina | |
CL2017000064A1 (es) | Vacunas contra virus influenza y usos de las mismas | |
CL2015001916A1 (es) | Derivados de pirimidona y su uso en el tratamiento, mejora o prevención de una enfermedad viral. | |
BR112015014482A2 (pt) | vacinas para vírus influenza e seus usos | |
CL2015003117A1 (es) | Modificaciones en la estructura cristalina | |
CR20150170A (es) | Vacunas de inmersión subunidad para peces | |
BR112017008266A2 (pt) | partículas semelhantes a vírus modificadas de cmv | |
MX342716B (es) | Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza. | |
MX2020004543A (es) | Vacunas contra el zika, composiciones inmunogenicas y metodos que las utilizan. | |
DK3436437T3 (da) | Substituerede indolinderivativer som dengue¬virus-replikations¬hæmmere | |
CL2017000063A1 (es) | Vacunas contra virus influenza y usos de las mismas | |
CO6761335A2 (es) | Inhibidores del virus de la hepatitis c | |
BRPI0923448A2 (pt) | vírus influenza rearranjado, composição antigênica de vírus influenza rearranjado, vacina, e, métodos para provocar uma resposta imune a pelo menos uma cepa pandêmica de vírus influenza em um indivíduo, para prevenir infecção de um indivíduo por um vírus influenza, e para preparar uma vacina. | |
NZ630869A (en) | Compositions and methods for dengue virus chimeric constructs in vaccines | |
BR112017003462A2 (pt) | coronavírus bovino atenuado, vacina, e, método de vacinação de um bovino. | |
UY34066A (es) | Inhibidores del virus de la hepatitis c | |
DOP2015000117A (es) | Derivados de n-(piridin-2-il)pirimidin-4-amina que contienen un grupo sulfoximina | |
CR20160178A (es) | Derivados de desoxinojirimicina y sus métodos de uso | |
ES2561538T3 (es) | Composiciones que comprenden bacteriófagos líticos de Salmonella UAB_Phi20, UAB_Phi78 y UAB_ Phi87 y usos de los mismos | |
PE20170185A1 (es) | Composiciones farmaceuticas para tratar enfermedades infecciosas | |
CO7461135A2 (es) | Parvovirus porcino 5b, métodos de uso y vacuna |